BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 30970203)

  • 21. Topical therapies in hyperhidrosis care.
    Pariser DM; Ballard A
    Dermatol Clin; 2014 Oct; 32(4):485-90. PubMed ID: 25152341
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Urinary retention and mydriasis secondary to topical glycopyrronium for axillary hyperhidrosis.
    Green HH; Ray L; Buchanan J; Matsler N
    Am J Health Syst Pharm; 2023 Sep; 80(18):1234-1237. PubMed ID: 37348110
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Topical Anticholinergics in the Management of Focal Hyperhidrosis in Adults and Children. A Narrative Review.
    Morgado-Carrasco D; de Lucas R
    Actas Dermosifiliogr; 2024 Apr; 115(4):356-367. PubMed ID: 37714301
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Therapeutic Hotline: Topical glycopyrrolate: a successful treatment for craniofacial hyperhidrosis and eccrine hidrocystomas.
    Garnacho Saucedo GM; Moreno Jiménez JC; Jiménez Puya R; Rodríguez Bujaldon A
    Dermatol Ther; 2010; 23(1):94-7. PubMed ID: 20136914
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of Systemic Therapies to Manage Focal Hyperhidrosis.
    Glaser DA; Glaser K
    Mo Med; 2015; 112(4):287-91. PubMed ID: 26455059
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treating hyperhidrosis. Anticholinergic drugs were not mentioned.
    Klaber M; Catterall M
    BMJ; 2000 Sep; 321(7262):703. PubMed ID: 11202933
    [No Abstract]   [Full Text] [Related]  

  • 27. Axillary hyperhidrosis: a focused review.
    Sammons JE; Khachemoune A
    J Dermatolog Treat; 2017 Nov; 28(7):582-590. PubMed ID: 28318360
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Topical glycopyrrolate reduces axillary hyperhidrosis.
    Baker DM
    J Eur Acad Dermatol Venereol; 2016 Dec; 30(12):2131-2136. PubMed ID: 27406319
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy and safety of topical glycopyrrolate in patients with facial hyperhidrosis: a randomized, multicentre, double-blinded, placebo-controlled, split-face study.
    Hyun MY; Son IP; Lee Y; Choi HG; Park KY; Li K; Kim BJ; Seo SJ; Kim MN; Hong CK
    J Eur Acad Dermatol Venereol; 2015 Feb; 29(2):278-282. PubMed ID: 24909188
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Treatment of primary hyperhidrosis with oral anticholinergic medications: a systematic review.
    Cruddas L; Baker DM
    J Eur Acad Dermatol Venereol; 2017 Jun; 31(6):952-963. PubMed ID: 27976476
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Efficacy and safety of topical sofpironium bromide gel for the treatment of axillary hyperhidrosis: A phase II, randomized, controlled, double-blinded trial.
    Kirsch B; Smith S; Cohen J; DuBois J; Green L; Baumann L; Bhatia N; Pariser D; Liu PY; Chadha D; Walker P
    J Am Acad Dermatol; 2020 Jun; 82(6):1321-1327. PubMed ID: 32068049
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pharmacologic mydriasis in an infant following parental use of topical glycopyrronium tosylate.
    Seto S; Teo AA; Walsh RD
    J AAPOS; 2019 Dec; 23(6):359-361. PubMed ID: 31683011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term efficacy and safety of 1% glycopyrronium bromide cream in patients with severe primary axillary hyperhidrosis: Results from a Phase 3b trial.
    Szeimies RM; Abels C; Kilic A; Reich H; Berger B; Schulze Zur Wiesche E; Schramm K; Litzka L; Heimstaedt-Muskett S; Masur C
    J Eur Acad Dermatol Venereol; 2023 Apr; 37(4):823-830. PubMed ID: 36606529
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Craniofacial hyperhidrosis successfully treated with topical glycopyrrolate.
    Luh JY; Blackwell TA
    South Med J; 2002 Jul; 95(7):756-8. PubMed ID: 12144084
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacologic anisocoria secondary to topical glycopyrronium for axillary hyperhidrosis: an emerging clinical presentation.
    Kaufman AR; Gulati S; Curnyn KM
    Can J Ophthalmol; 2020 Oct; 55(5):464. PubMed ID: 32735775
    [No Abstract]   [Full Text] [Related]  

  • 36. Systemic treatment of hyperhidrosis.
    del Boz J
    Actas Dermosifiliogr; 2015 May; 106(4):271-7. PubMed ID: 25638324
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Use of topical 2.4% glycopyrronium tosylate in familial benign pemphigus (Hailey-Hailey disease).
    Bindernagel R; Kimmis BD; Liu D
    Dermatol Online J; 2020 Oct; 26(10):. PubMed ID: 33147680
    [No Abstract]   [Full Text] [Related]  

  • 38. Topical glycopyrrolate for axillary hyperhidrosis.
    Mackenzie A; Burns C; Kavanagh G
    Br J Dermatol; 2013 Aug; 169(2):483-4. PubMed ID: 23496205
    [No Abstract]   [Full Text] [Related]  

  • 39. A glycopyrronium bromide 1% cream for topical treatment of primary axillary hyperhidrosis: efficacy and safety results from a phase IIIa randomized controlled trial.
    Abels C; Soeberdt M; Kilic A; Reich H; Knie U; Jourdan C; Schramm K; Heimstaedt-Muskett S; Masur C; Szeimies RM
    Br J Dermatol; 2021 Aug; 185(2):315-322. PubMed ID: 33445205
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Successful treatment of diabetic gustatory hyperhidrosis with topical glycopyrrolate].
    Lund NS; Maxel T; Rungby J
    Ugeskr Laeger; 2011 Sep; 173(36):2200-1. PubMed ID: 21893005
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.